Literature DB >> 1692070

Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells.

W Allan1, Z Tabi, A Cleary, P C Doherty.   

Abstract

The cellularity of the mediastinal lymph nodes of mice infected intranasally with a high dose of an H3N2 influenza A virus increases massively within 5 days. All classes of lymphocytes are involved. A similar, but much smaller, expansion in cell numbers occurs after exposure to a comparable dilution of normal chick allantoic fluid. In the control group, this increase in lymph node size is totally prevented by the in vivo depletion of CD4+ T cells whereas there is only a 50% reduction in the virus-infected mice. The lymphocyte component of the cellular exudate in the lungs of infected mice is dominated by activated, CD8+ T cells, which are also prevalent in the mediastinal lymph nodes. Elimination of the CD4+ subset does not greatly diminish the severity of this inflammatory process. The CD4-depleted mice clear the virus from the lung, and there is little effect on the frequency of virus-specific, cytotoxic T lymphocyte precursors in either the lymph node or the lung. Substantial involvement of CD4+ T cells is not essential for the development of effective cell-mediated immunity in mice with influenza.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692070

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  140 in total

1.  In vivo proliferation of naïve and memory influenza-specific CD8(+) T cells.

Authors:  K J Flynn; J M Riberdy; J P Christensen; J D Altman; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma.

Authors:  J P Christensen; R D Cardin; K C Branum; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Diminished primary and secondary influenza virus-specific CD8(+) T-cell responses in CD4-depleted Ig(-/-) mice.

Authors:  J M Riberdy; J P Christensen; K Branum; P C Doherty
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice.

Authors:  Gabrielle T Belz; Dominik Wodarz; Gabriela Diaz; Martin A Nowak; Peter C Doherty
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus.

Authors:  S R Sarawar; B J Lee; S K Reiter; S P Schoenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

6.  IL-4 acts as a potent stimulator of IFN-γ expression in CD8+ T cells through STAT6-dependent and independent induction of Eomesodermin and T-bet.

Authors:  Jennifer A Oliver; Valerie R Stolberg; Stephen W Chensue; Philip D King
Journal:  Cytokine       Date:  2011-11-09       Impact factor: 3.861

7.  Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory.

Authors:  J P Christensen; P C Doherty; K C Branum; J M Riberdy
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  Quantitative analysis of long-term virus-specific CD8+-T-cell memory in mice challenged with unrelated pathogens.

Authors:  Haiyan Liu; Samita Andreansky; Gabriela Diaz; Stephen J Turner; Dominik Wodarz; Peter C Doherty
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis.

Authors:  J J Goronzy; P Bartz-Bazzanella; W Hu; M C Jendro; D R Walser-Kuntz; C M Weyand
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves.

Authors:  G Taylor; L H Thomas; S G Wyld; J Furze; P Sopp; C J Howard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.